Anthraquinones from the seeds of Cassia tora with inhibitory activity on protein glycation and aldose reductase

被引:79
作者
Jang, Dae Sik [1 ]
Lee, Ga Young [1 ]
Kim, Young Sook [1 ]
Lee, Yun Mi [1 ]
Kim, Chan-Sik [1 ]
Yoo, Jeong Lim [1 ]
Kim, Jin Sook [1 ]
机构
[1] Korea Inst Oriental Med, Dept Herbal Pharmaceut Dev, Taejon 305811, South Korea
关键词
Cassia tora; Leguminosae; anthraquinone; advanced glycation end product; aldose reductase;
D O I
10.1248/bpb.30.2207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nine anthraquinones, aurantio-obtusin (1), chryso-obtusin (2), obtusin (3), chryso-obtusin-2-O-beta-D-glucoside (4), physcion (5), emodin (6), chrysophanol (7), obtusifolin (8), and obtusifolin-2-O-beta-D-glucoside (9), isolated from an EtOAc-soluble extract of the seeds of Cassia tora, were subjected to in vitro bioassays to evaluate their inhibitory activity against advanced glycation end products (AGEs) formation and rat lens aldose reductase (RLAR). Among the isolates, compounds 6 and 8 exhibited a significant inhibitory activity on AGEs formation with observed IC50 values of 118 and 28.9 mu M, respectively, in an AGEs-bovine serum albumin (BSA) assay by specific fluorescence. Furthermore, compounds 6 and 8 inhibited AGEs-BSA formation more effectively than aminoguanidine, an AGEs inhibitor, by indirect AGEs-ELISA. N-epsilon-Carboxymethyllysine (CML)-BSA formation was also inhibited by compounds 6 and 8. Whereas compounds 1, 4, and 6 showed a significant inhibitory activity on RLAR with IC50 values of 13.6, 8.8, and 15.9 mu M, respectively.
引用
收藏
页码:2207 / 2210
页数:4
相关论文
共 32 条
[1]   Advanced glycation endproducts - role in pathology of diabetic complications [J].
Ahmed, N .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) :3-21
[2]   REVERSAL OF DIABETIC CATARACT BY SORBINIL, AN ALDOSE REDUCTASE INHIBITOR [J].
BEYERMEARS, A ;
CRUZ, E .
DIABETES, 1985, 34 (01) :15-21
[3]   Advanced glycosylation end products in diabetic renal and vascular disease [J].
Bucala, R ;
Vlassara, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (06) :875-888
[4]  
Choi Jae Sue, 1994, Archives of Pharmacal Research (Seoul), V17, P462, DOI 10.1007/BF02979126
[5]   The NMR assignments of anthraquinones from Cassia tora [J].
Choi, JS ;
Jung, JH ;
Lee, HJ ;
Kang, SS .
ARCHIVES OF PHARMACAL RESEARCH, 1996, 19 (04) :302-306
[6]   In vitro antimutagenic effects of anthraquinone aglycones and naphthopyrone glycosides from Cassia tora [J].
Choi, JS ;
Lee, HJ ;
Park, KY ;
Ha, JO ;
Kang, SS .
PLANTA MEDICA, 1997, 63 (01) :11-14
[7]  
Engvall E, 1980, Methods Enzymol, V70, P419
[8]   Role of advanced glycation end products in diabetic nephropathy [J].
Forbes, JM ;
Cooper, ME ;
Oldfield, MD ;
Thomas, MC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 :S254-S258
[9]  
Hatano T, 1999, CHEM PHARM BULL, V47, P1121, DOI 10.1248/cpb.47.1121
[10]   Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata [J].
Jang, Dae Sik ;
Kim, Jong Min ;
Lee, Yun Mi ;
Kim, Young Sook ;
Kim, Joo-Hwan ;
Kim, Jin Sook .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (09) :1315-1317